Comprehensive Metabolic Panel (CMP) Testing Market, By Analytes (K+, Na+, Cl-, CO2, and Glucose), By Disease, By End-use , By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Comprehensive Metabolic Panel (CMP) Testing Market size was valued at USD 12,645 Million in 2024, expanding at a CAGR of 9.4% from 2024 to 2032.
A Comprehensive Metabolic Panel (CMP) is a blood test that measures 14 different substances to assess the body’s chemical balance and metabolic function. It provides valuable insights into organ health, particularly the liver and kidneys, and helps monitor conditions such as diabetes, liver disease, and electrolyte imbalances. The CMP evaluates glucose levels, calcium, electrolytes (including sodium, potassium, carbon dioxide, and chloride), kidney function markers (BUN and creatinine), and liver enzymes (ALP, ALT, AST, bilirubin), as well as albumin and total protein. Commonly included in routine health checkups, the CMP plays a crucial role in early disease detection and ongoing health monitoring, enabling timely medical intervention.
Comprehensive Metabolic Panel (CMP) Testing Market- Market Dynamics
Rising Demand for Preventive Healthcare
The growing focus on preventive healthcare is a key driver of the Comprehensive Metabolic Panel (CMP) testing market. As awareness about early diagnosis and effective disease management increases, both patients and healthcare providers are placing greater importance on routine health screenings. CMP tests, which provide a comprehensive overview of organ function and metabolic health, have become vital tools for detecting potential health issues before symptoms arise. Moreover, the rising prevalence of chronic diseases such as diabetes, kidney disease, and liver disorders is further boosting demand. According to the World Health Organization, over 60% of global deaths are attributable to chronic diseases, prompting governments worldwide to implement policies promoting preventive screenings and early diagnosis. Supportive government initiatives and expanding insurance coverage for preventive healthcare are also contributing to the market’s growth.
Comprehensive Metabolic Panel (CMP) Testing Market- Segmentation Analysis:
The global Comprehensive Metabolic Panel (CMP) Testing Market is divided into Four categories: Analytes, Disease, End-use, and Region.
The Comprehensive Metabolic Panel (CMP) testing market is segmented by analytes into potassium (K), sodium (Na), chloride (Cl), carbon dioxide (CO), glucose, blood urea nitrogen (BUN), creatinine, calcium (Ca²), albumin, total protein, alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin. Among these analytes, glucose testing dominates the market, driven by the global rise in diabetes and prediabetes cases. Early detection of abnormal blood sugar levels is vital for effective management of metabolic disorders and prevention of serious complications. Consequently, glucose analysis is routinely included in general health checkups as well as disease-specific screenings. The surge in demand for point-of-care testing and home-based glucose monitoring devices has further expanded the accessibility and frequency of glucose testing, reinforcing its leadership within CMP analytes. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide were living with diabetes in 2021, a figure expected to rise to 643 million by 2030, underscoring the critical role of glucose testing in healthcare.
By disease, the CMP testing market is divided into kidney diseases, liver diseases, diabetes, and others. Diabetes stands out as the dominant segment due to its widespread prevalence and the significant global health burden it imposes. CMP tests are essential for diagnosing and monitoring diabetes by measuring blood glucose levels and evaluating kidney and liver functions, which are often impacted by the disease. The rising incidence of type 2 diabetes, fueled by sedentary lifestyles, unhealthy diets, and aging populations, has increased the necessity for routine metabolic assessments. Additionally, public health initiatives and government programs aimed at raising awareness, encouraging early detection, and promoting preventive care have significantly driven the demand for CMP testing in diabetes management. The U.S. Centers for Disease Control and Prevention (CDC) reports that diabetes affects over 37 million Americans, highlighting the ongoing need for comprehensive metabolic testing to manage this chronic condition effectively.
Comprehensive Metabolic Panel (CMP) Testing Market- Geographical Insights
Geographically, the Comprehensive Metabolic Panel (CMP) Testing Market spans North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa, with each region segmented by key contributing countries.
North America leads the CMP testing market, driven by its advanced healthcare infrastructure, substantial healthcare expenditure, and widespread adoption of preventive care practices. The United States plays a pivotal role, owing to the high prevalence of chronic diseases such as diabetes, kidney disorders, and liver conditions. Strong insurance coverage and routine health screening programs further elevate demand for CMP tests. Additionally, the presence of prominent diagnostic laboratories and growing public awareness about early disease detection significantly contribute to the region’s market dominance. Strategic initiatives by healthcare providers, alongside supportive government policies—including the U.S. Preventive Services Task Force recommendations and Medicare coverage for routine metabolic panels—reinforce North America’s leadership position in the global CMP testing market.
Meanwhile, Asia Pacific is emerging as a key growth region, propelled by the rising incidence of chronic diseases and increasing healthcare awareness. Countries including China, India, and Japan are witnessing a surge in diagnostic testing demand driven by rapid urbanization, lifestyle changes, and expanding middle-class populations. Governments across the region are actively investing in healthcare infrastructure and implementing preventive health programs—such as India’s National Health Mission and China’s Healthy China 2030 initiative—to support market growth. Improvements in affordability and accessibility of diagnostic services through public and private healthcare expansions also enhance the region’s market potential. Collectively, these factors establish Asia Pacific as one of the most promising markets for CMP testing globally.
Comprehensive Metabolic Panel (CMP) Testing Market- Competitive Landscape:
The Comprehensive Metabolic Panel (CMP) testing market is dominated by established diagnostic leaders such as Abbott, Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), and Sonic Healthcare. These companies offer a wide array of metabolic and biochemical tests known for their high accuracy and reliability. Significant investments in research and development, along with the adoption of advanced diagnostic technologies, enable them to maintain regulatory compliance and drive continuous product innovation. Emerging players are increasingly focusing on integrating artificial intelligence and point-of-care testing solutions to enhance diagnostic speed and accessibility. This competitive landscape fosters ongoing improvements in testing efficiency, accuracy, and convenience, promoting broader adoption of CMP testing in both clinical and preventive healthcare settings worldwide.
Recent Developments:
- In March 2024, Abbott launched a next-generation point-of-care blood analyzer designed for rapid metabolic panel testing, significantly improving turnaround times and accessibility in remote healthcare locations.
- In January 2025, Quest Diagnostics expanded its laboratory services by inaugurating a state-of-the-art testing facility in Texas, increasing capacity for metabolic and genetic testing to meet growing market demand.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott
- Quest Diagnostics
- Laboratory Corporation of America Holdings Limited
- Sonic Healthcare
- Unipath
- SYNLAB International GmbH
- ARUP Laboratories
- Genoptix Inc.
- Nova Medical
- Others
GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY ANALYTES - MARKET ANALYSIS, 2019 - 2032
- K+
- Na+
- Cl-
- CO2
- Glucose
- BUN
- Creatinine
- Ca++
- Albumin
- Total Protein
- ALP
- ALT
- AST
- Total Bilirubin
GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY DISEASE - MARKET ANALYSIS, 2019 - 2032
- Kidney Diseases
- Liver Diseases
- Diabetes
- Others
GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032
- Laboratories
- Emergency Departments
- Hospital Wards
- Primary Care
- Pharmacy
- Telemedicine
- PoC
- Emergency Departments
- Hospital Wards
- Primary Care
- Pharmacy
- Telemedicine
- PoC (Instruments)
- Piccolo Xpress
- Skyla-HB1
- DRI-CHEM NX500
- Others
GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Comprehensive Metabolic Panel (CMP) Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Analytes
2.1.2. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Disease
2.1.3. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by End Use
2.1.4. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Country
2.1.5. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Region
2.2. Competitive Insights
3. Comprehensive Metabolic Panel (CMP) Testing Key Market Trends
3.1. Comprehensive Metabolic Panel (CMP) Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Comprehensive Metabolic Panel (CMP) Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Comprehensive Metabolic Panel (CMP) Testing Market Opportunities
3.4. Comprehensive Metabolic Panel (CMP) Testing Market Future Trends
4. Comprehensive Metabolic Panel (CMP) Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Comprehensive Metabolic Panel (CMP) Testing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Comprehensive Metabolic Panel (CMP) Testing Market Landscape
6.1. Comprehensive Metabolic Panel (CMP) Testing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Comprehensive Metabolic Panel (CMP) Testing Market – By Analytes
7.1. Overview
7.1.1. Segment Share Analysis, By Analytes, 2023 & 2032 (%)
7.1.2. K+
7.1.3. Na+
7.1.4. Cl-
7.1.5. CO2
7.1.6. Glucose
7.1.7. BUN
7.1.8. Creatinine
7.1.9. Ca++
7.1.10. Albumin
7.1.11. Total Protein
7.1.12. ALP
7.1.13. ALT
7.1.14. AST
7.1.15. Total Bilirubin
8. Comprehensive Metabolic Panel (CMP) Testing Market – By Disease
8.1. Overview
8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
8.1.2. Kidney Diseases
8.1.3. Liver Diseases
8.1.4. Diabetes
8.1.5. Others
9. Comprehensive Metabolic Panel (CMP) Testing Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
9.1.2. Laboratories
9.1.2.1. Emergency Departments
9.1.2.2. Hospital Wards
9.1.2.3. Primary Care
9.1.2.4. Pharmacy
9.1.2.5. Telemedicine
9.1.3. PoC
9.1.3.1. Emergency Departments
9.1.3.2. Hospital Wards
9.1.3.3. Primary Care
9.1.3.4. Pharmacy
9.1.3.5. Telemedicine
9.1.4. PoC (Instruments)
9.1.4.1. Piccolo Xpress
9.1.4.2. Skyla-HB1
9.1.4.3. DRI-CHEM NX500
9.1.4.4. Others
10. Comprehensive Metabolic Panel (CMP) Testing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.8. France
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. France Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.8.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. Italy Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.9.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.10. Spain
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. United Kingdom Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.10.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.11. United Kingdom
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. United Kingdom Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.11.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.12. Russia
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Russia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.12.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.13. Netherlands
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Netherlands Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.13.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.14. Sweden
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Sweden Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.14.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.2. Poland Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.9. South Korea
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. South Korea Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.4.9.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. Japan Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.4.10.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Comprehensive Metabolic Panel (CMP) Testing Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Abbott
11.2.2. Quest Diagnostics
11.2.3. Laboratory Corporation of America Holdings Limited
11.2.4. Sonic Healthcare
11.2.5. Unipath
11.2.6. SYNLAB International GmbH
11.2.7. ARUP Laboratories
11.2.8. Genoptix Inc.
11.2.9. Nova Medical
11.2.10. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
